BCAL Diagnostics (ASX:BDX) and Precion partner for breast cancer product development
BCAL Diagnostics (BDX) signs an agreement with US company Precion to further…
Bcal Diagnostics Limited (ASX:BDX)
About Bcal Diagnostics Limited
Key Information
BDX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 03/04/2024 | Initial Director's Interest Notice | 102.35KB | 242 |
| 03/04/2024 | Ceasing to be a substantial holder | 148.27KB | 180 |
| 02/04/2024 | Trademark Registrations Received Ahead of Commercial Launch | 215.81KB | 156 |
| 27/03/2024 | Change in substantial holding | 225.57KB | 1.0K |
| 06/03/2024 | Corporate Presentation | 3.52MB | 6.3K |
| 06/03/2024 | Price Sensitive PS Appointment of Strategic CEO to Lead Commercial Launch | 217.93KB | 482 |
| 04/03/2024 | Initial Director's Interest Notice | 100.22KB | 121 |
| 04/03/2024 | Final Director's Interest Notice | 113.95KB | 98 |